Trade Mark Journal No.2026/045 6 November 2026
WO0000001930158 (1,5,9,10)
Office of origin: United States of America
Date of International Registration:1 June 2026
Date of designation in the UK:
1 June 2026
International priority date claimed: 3 December 2025
(United States of America)
(99527273)
- Class 1
- Diagnostic reagents for scientific purposes; buffer solutions for scientific purposes; diagnostic preparations for research laboratory use.
- Class 5
- Diagnostic kits comprised of assays for testing of bodily fluids for use in disease detection; diagnostic kits comprising primarily diagnostic agents, preparations and substances for medical purposes; diagnostic kits comprised of medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents, preparations and substances for medical purposes.
- Class 9
- Scientific apparatus for diagnostic testing of biological samples, other than for medical purposes; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; diagnostic apparatus for research laboratory use for processing samples; diagnostic apparatus for the detection of pathogens, not for medical purposes; downloadable medical software for processing biological samples.
- Class 10
- Scientific apparatus for diagnostic testing of biological samples, for medical purposes; diagnostic instruments for medical purposes used for analyzing body fluids; medical diagnostic apparatus for testing pathogens; medical diagnostic apparatus for testing of biological samples incorporating recorded software for processing the biological samples; medical diagnostic apparatus for testing biological samples incorporating recorded operating system software.
Gen-Probe Incorporated
Representative: Charles F. Reidelbach, Jr. Higgs Fletcher & Mack LLP, 401 West A Street, Suite 2600, San Diego CA 92101, UNITED STATES OF AMERICA